PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

methylphenidate Side Effects

The reactions most often reported to the FDA for methylphenidate (also sold as Ritalin, Concerta), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

27,931
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of methylphenidate come from 27,931 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 27,931 reports to the FDA Adverse Event Reporting System (FAERS) for methylphenidate (Ritalin): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

27,931

Reports Mentioning Death

1,071

3.8% of reports — not proof the medicine caused the death

Hospitalizations

3,510

12.6% of reports

Top Indication

Attention Deficit/Hyperactivity Disorder

Most Reported Adverse Reactions

PRODUCT QUALITY ISSUE
5,241
DRUG ADMINISTRATION ERROR
1,901
WRONG TECHNIQUE IN DRUG USAGE PROCESS
1,772
APPLICATION SITE ERYTHEMA
1,684
DRUG DOSE OMISSION
1,478
INCORRECT DRUG ADMINISTRATION DURATION
1,191
DRUG PRESCRIBING ERROR
1,079
DISTURBANCE IN ATTENTION
907
PRODUCT ADHESION ISSUE
867
ANXIETY
833
FATIGUE
823
APPLICATION SITE PRURITUS
811
HEADACHE
808
DECREASED APPETITE
788
NAUSEA
780
INSOMNIA
707

Who Reports Side Effects

Gender Distribution

Female 9,827 (44%)
Male 12,026 (54%)
Unknown 306

Age Distribution

0-17 6,627 (49%)
18-44 3,875 (29%)
45-64 2,183 (16%)
65-74 588 (4%)
75+ 290 (2%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 1,071 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
COMPLETED SUICIDE 276
TOXICITY TO VARIOUS AGENTS 273
DEATH 210
DRUG ABUSE 164
OVERDOSE 109
CARDIO-RESPIRATORY ARREST 107
CARDIAC ARREST 77
POISONING 71
DRUG DEPENDENCE 61
ARTERIOSCLEROSIS CORONARY ARTERY 52
RESPIRATORY ARREST 38
UNRESPONSIVE TO STIMULI 38
INTENTIONAL OVERDOSE 37
DRUG LEVEL INCREASED 34
INTENTIONAL PRODUCT MISUSE 31
PULMONARY OEDEMA 27
SUSPECTED SUICIDE 24
FATIGUE 22
HYPOTENSION 22

Reactions in Hospitalization Reports

Top reactions in 3,510 reports where hospitalization was an outcome.

Reaction Reports
TOXICITY TO VARIOUS AGENTS 418
AGITATION 224
TACHYCARDIA 206
NAUSEA 188
INTENTIONAL OVERDOSE 179
VOMITING 179
ANXIETY 168
HYPERTENSION 168
HEADACHE 162
FATIGUE 159
DRUG INTERACTION 158
OVERDOSE 155
DRUG ABUSE 149
SUICIDE ATTEMPT 142
DIZZINESS 130
INSOMNIA 127
CONFUSIONAL STATE 125
CONDITION AGGRAVATED 124

Compare methylphenidate vs acamprosate →

What the FAERS Data Reveals About methylphenidate Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 27,931 voluntary reports linked to methylphenidate and its brand equivalents (Ritalin, Concerta), spanning 2004 through 2025. Of those, 1,071 (3.8%) listed death as an outcome and 3,510 (12.6%) involved hospitalization. The most common indication reported alongside adverse events was Attention Deficit/Hyperactivity Disorder.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 44% were female and 54% male; age distribution skews toward 0-17, with 6,627 reports in that bracket. The single most reported reaction is product quality issue with 5,241 submissions, followed by drug administration error and wrong technique in drug usage process.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.

Drugs With a Similar FAERS Report Volume

Other medications with a total FDA adverse-event report count closest to methylphenidate's 27,931.